Katherine A Laessig MD
Deputy Director, Division of Anti-infective Products, FDA
Join to View Full Profile
170114th Street NWWashington, DC 20009
Phone+1 202-745-7000
Fax+1 202-745-0238
Dr. Laessig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
George Washington UniversityFellowship, Infectious Disease, 1995 - 1997- George Washington UniversityResidency, Internal Medicine, 1992 - 1995
University of Maryland School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1997 - 2026
VA State Medical License 1997 - 2026
DC State Medical License 1996 - 2016
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 21 citationsEnd Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration PerspectiveKatherine A. Laessig
Clinical Infectious Diseases. 2010-08-01 - 16 citationsDevelopment of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.Kenneth E. Sherman, Russell Fleischer, Katherine A. Laessig, Jeffrey Murray, William Tauber
Hepatology. 2007-12-01 - Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.Katherine A Laessig, Linda L Lewis, Thomas S Hammerstrom
The New England Journal of Medicine. 2006-06-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
